Alexion Pharmaceuticals, Inc. et al v. Samsung Bioepis Co. Ltd.
Plaintiff: Alexion Pharmaceuticals, Inc. and Alexion Pharma International Operations Ltd.
Defendant: Samsung Bioepis Co. Ltd.
Case Number: 1:2024cv00005
Filed: January 3, 2024
Court: US District Court for the District of Delaware
Presiding Judge: Gregory B Williams
Nature of Suit: Patent
Cause of Action: 35 U.S.C. § 271 Patent Infringement
Jury Demanded By: Defendant
Docket Report

This docket was last retrieved on February 27, 2024. A more recent docket listing may be available from PACER.

Date Filed Document Text
February 27, 2024 Filing 35 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Preliminary Injunction Discovery Requests for Production of Documents and Things (Nos. 1-4) filed by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc..(Joyce, Alexandra)
February 27, 2024 Filing 34 REDACTED VERSION of #27 Stipulation by Samsung Bioepis Co. Ltd.. (Mayo, Andrew)
February 27, 2024 Opinion or Order SO ORDERED, re #32 MOTION for Pro Hac Vice Appearance of Attorney Brianna Patterson filed by Samsung Bioepis Co. Ltd. Signed by Judge Gregory B. Williams on 2/27/24. (ntl)
February 27, 2024 Pro Hac Vice Attorney Brianna Patterson for Samsung Bioepis Co. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
February 26, 2024 Filing 33 Pro Hac Vice Fee - Credit Card Payment received for Brianna Patterson. ( re #32 MOTION for Pro Hac Vice Appearance of Attorney Brianna Patterson )( Payment of $ 50, receipt number ADEDC-4347505).(Mayo, Andrew)
February 26, 2024 Filing 32 MOTION for Pro Hac Vice Appearance of Attorney Brianna Patterson - filed by Samsung Bioepis Co. Ltd.. (Mayo, Andrew)
February 23, 2024 Filing 31 REDACTED VERSION of #19 Declaration, of Andrew Cochran, Esq. by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc.. (Attachments: #1 Exhibits A - L, #2 Exhibits M - U)(Joyce, Alexandra)
February 23, 2024 Filing 30 REDACTED VERSION of #18 Declaration, of Vincent A. Thomas, CPA, CVA, ABV, CFF, CPVA, CLP by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc.. (Joyce, Alexandra)
February 23, 2024 Filing 29 REDACTED VERSION of #17 Opening Brief in Support, Motion for Preliminary Injunction by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc.. (Joyce, Alexandra)
February 22, 2024 Pro Hac Vice Attorney Jonathan R. Davies for Samsung Bioepis Co. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)
February 21, 2024 Pro Hac Vice Attorneys Orion Armon and Daniel J. Knauss for Samsung Bioepis Co. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
February 20, 2024 Opinion or Order Filing 28 [SEALED] SO ORDERED, re #27 Stipulation and Order Regarding Preliminary Injunction Schedule -- A Hearing on the Motion is set for 5/8/2024 at 10:00 AM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 2/20/24. This order has been emailed to Delaware counsel. (ntl)
February 20, 2024 Opinion or Order SO ORDERED, re #26 STIPULATION TO EXTEND TIME to asnwer, move, or otherwise respond to Defendant/Counterclaim Plaintiff Samsung Bioepis Co., Ltd.'s counterclaims to March 14, 2024 filed by Alexion Pharmaceuticals, Inc., Alexion Pharma International Operations Ltd. Signed by Judge Gregory B. Williams on 2/20/24. (ntl)
February 20, 2024 Pro Hac Vice Attorney Michelle S. Rhyu for Samsung Bioepis Co. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
February 19, 2024 Filing 27 [SEALED] STIPULATION and [Proposed] Order Regarding Preliminary Injunction Schedule, by Samsung Bioepis Co. Ltd.. (Mayo, Andrew)
February 16, 2024 Filing 26 STIPULATION TO EXTEND TIME to asnwer, move, or otherwise respond to Defendant/Counterclaim Plaintiff Samsung Bioepis Co., Ltd.'s counterclaims to March 14, 2024 - filed by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc.. (Joyce, Alexandra)
February 15, 2024 Filing 25 NOTICE OF SUBSTITUTION OF COUNSEL re Samsung Bioepis Co. Ltd.: Entry of appearance of attorney Andrew Colin Mayo. Attorney Melanie K. Sharp, James L. Higgins and Taylor E. Hallowell terminated. (Mayo, Andrew)
February 14, 2024 Filing 24 NOTICE OF SERVICE of Samsung Bioepis Co. Ltd.'s Preliminary Injunction Discovery - Requests for Production of Documents and Things (Nos. 1-4) filed by Samsung Bioepis Co. Ltd..(Higgins, James)
February 14, 2024 Filing 23 NOTICE to Take Deposition of Vincent A. Thomas on March 5, 2024 filed by Samsung Bioepis Co. Ltd..(Higgins, James)
February 13, 2024 Opinion or Order Filing 22 ORDER re #15 Unopposed MOTION to Seal filed by Alexion Pharmaceuticals, Inc., Alexion Pharma International Operations Ltd. Signed by Judge Gregory B. Williams on 2/13/24. (ntl)
February 12, 2024 Filing 21 DECLARATION re #16 MOTION for Preliminary Injunction Declaration of Bernhardt L. Trout, Ph.D. by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc.. (Silver, Daniel)
February 12, 2024 Filing 20 DECLARATION re #16 MOTION for Preliminary Injunction Declaration of Arturo Casadevali, M.D., Ph.D. by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc.. (Silver, Daniel)
February 12, 2024 Filing 19 [SEALED] DECLARATION re #16 MOTION for Preliminary Injunction Declaration of Andrew Cochran, Esq. by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc.. (Attachments: #1 Exhibits A - L, #2 Exhibits M - U)(Silver, Daniel) Modified on 2/22/2024 (ntl).
February 12, 2024 Filing 18 [SEALED] DECLARATION re #17 Opening Brief in Support, Declaration of Vincent A. Thomas, CPA, CVA, ABV, CFF, CPVA, CLP by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc.. (Attachments: #1 Certificate of Service)(Silver, Daniel)
February 12, 2024 Filing 17 [SEALED] OPENING BRIEF in Support re #16 MOTION for Preliminary Injunction filed by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc..Answering Brief/Response due date per Local Rules is 2/26/2024. (Attachments: #1 Certificate of Service)(Silver, Daniel)
February 12, 2024 Filing 16 MOTION for Preliminary Injunction - filed by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc.. (Attachments: #1 Proposed Order, #2 Rule 7.1.1 Certification)(Silver, Daniel)
February 12, 2024 Filing 15 Unopposed MOTION to Seal - filed by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc.. (Attachments: #1 Proposed Order)(Joyce, Alexandra)
February 9, 2024 Opinion or Order SO ORDERED, re #13 MOTION for Pro Hac Vice Appearance of Attorney Michelle S. Rhyu, Daniel J. Knauss, Orion Armon, and Jonathan Davies filed by Samsung Bioepis Co. Ltd. Signed by Judge Gregory B. Williams on 2/9/24. (ntl)
February 8, 2024 Filing 14 Pro Hac Vice Fee - Credit Card Payment received for Michelle S. Rhyu, Daniel J. Knauss, Orion Armon, and Jonathan Davies. ( re #13 MOTION for Pro Hac Vice Appearance of Attorney Michelle S. Rhyu, Daniel J. Knauss, Orion Armon, and Jonathan Davies )( Payment of $ 200, receipt number ADEDC-4333912).(Higgins, James)
February 8, 2024 Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Michelle S. Rhyu, Daniel J. Knauss, Orion Armon, and Jonathan Davies - filed by Samsung Bioepis Co. Ltd.. (Higgins, James)
February 8, 2024 Filing 12 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Samsung BioLogics Co., Ltd., Other Affiliate Samsung Electronics Co., Ltd., Other Affiliate Samsung C&T Corporation for Samsung Bioepis Co. Ltd. filed by Samsung Bioepis Co. Ltd.. (Higgins, James)
February 8, 2024 Filing 11 ANSWER to #1 Complaint, with JURY DEMAND , COUNTERCLAIM against Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc. by Samsung Bioepis Co. Ltd.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Exhibit M)(Higgins, James)
January 23, 2024 Pro Hac Vice Attorney Gerald J. Flattmann, Jr for Alexion Pharma International Operations Ltd.,and Alexion Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)
January 23, 2024 Opinion or Order SO ORDERED, re #10 STIPULATION TO EXTEND TIME for Defendant to respond to Complaint to February 8, 2024 filed by Samsung Bioepis Co. Ltd. Signed by Judge Gregory B. Williams on 1/23/24. (ntl)
January 22, 2024 Filing 10 STIPULATION TO EXTEND TIME for Defendant to respond to Complaint to February 8, 2024 - filed by Samsung Bioepis Co. Ltd.. (Higgins, James)
January 22, 2024 Opinion or Order SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr. and Andrew J. Cochran filed by Alexion Pharmaceuticals, Inc., Alexion Pharma International Operations Ltd. Signed by Judge Gregory B. Williams on 1/22/24. (ntl)
January 18, 2024 Filing 9 Pro Hac Vice Fee - Credit Card Payment received for Gerald J. Flattmann and Andrew J. Cochran. ( re #8 MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr. and Andrew J. Cochran )( Payment of $ 100, receipt number ADEDC-4317233).(Joyce, Alexandra)
January 18, 2024 Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr. and Andrew J. Cochran - filed by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc.. (Joyce, Alexandra)
January 10, 2024 Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb)
January 8, 2024 Filing 7 DECLARATION of Service of Defendant Samsung Bioepis Co. Ltd. by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc.. (Joyce, Alexandra)
January 3, 2024 Filing 6 Summons Issued as to Samsung Bioepis Co. Ltd. on 1/3/2024. (mpb)
January 3, 2024 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Alexion Pharma International Operations Ltd. filed by Alexion Pharma International Operations Ltd.. (mpb)
January 3, 2024 Filing 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Alexion Pharmaceuticals, Inc. filed by Alexion Pharmaceuticals, Inc.. (mpb)
January 3, 2024 Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,732,149; 9,718,880; 9,725,504; 10,590,189; 10,703,809; 9,447,176. (Attachments: #1 Patent/Trademark Report)(mpb)
January 3, 2024 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb)
January 3, 2024 Filing 1 COMPLAINT filed against Samsung Bioepis Co. Ltd. ( Filing fee $ 405, receipt number ADEDC-4305458.) - filed by Alexion Pharmaceuticals, Inc., Alexion Pharma International Operations Ltd.. (Attachments: #1 Exhibits A-K, #2 Civil Cover Sheet)(mpb)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Alexion Pharmaceuticals, Inc. et al v. Samsung Bioepis Co. Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Alexion Pharmaceuticals, Inc.
Represented By: Daniel M. Silver
Represented By: Alexandra M. Joyce
Represented By: Maliheh Zare
Represented By: Gerald J. Flattmann, Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Alexion Pharma International Operations Ltd.
Represented By: Daniel M. Silver
Represented By: Alexandra M. Joyce
Represented By: Maliheh Zare
Represented By: Gerald J. Flattmann, Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Samsung Bioepis Co. Ltd.
Represented By: James L. Higgins
Represented By: Jonathan R. Davies
Represented By: Michelle S. Rhyu
Represented By: Orion Armon
Represented By: Andrew Colin Mayo
Represented By: Brianna Patterson
Represented By: Daniel J. Knauss
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?